European Archives - Page 669 of 1060 - European Medical Journal

Real-World Experience of Apremilast in Treating Psoriatic Arthritis Patients with Comorbidities

Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…

Progress In Understanding Endometriosis

PELVIC pain in women with endometriosis may be caused primarily by a type of white blood cell called macrophages that have been modified because…

Exercise the Key to Relieving Period Pain

PERIOD pain symptoms can be alleviated through exercising on a treadmill, according to the results of a clinical trial. The study suggests that in those…

An interview with Andrea Palmer from Publicis Health Media

We recently met with Andrea Palmer, President of Publicis Health Media at the 2019 Cannes Lions Festival of Creativity. In this interview Andrea talks about the new generation of HCP and how the pharma industry can meet the changing consumer expectations, as well as her own career and leadership success.

Curious Future Insight Conference and the Future Insight Prize: Merck’s Fight for a Better Tomorrow

At the Curious2018 – Future Insight Conference, as part of Merck’s 350th anniversary, Stefan Oschmann, CEO, Merck, announced the Future Insight Prize.

The European Medical Journal Presents: EMJ Allergy & Immunology 2019

In the newest edition of EMJ Allergy and Immunology, published today, results are presented from a study that compared Reflex Ridge active video game…

In Vitro Silencing of Y-RNA: A Potential New Tool for Studying an Epigenetic Mechanism Recently Described in Allergy

Allergic diseases are becoming a public health concern, their frequency has notably increased in the last decades, which is likely related…

Review of the European Academy of Allergy and Clinical Immunology (EAACI) Congress

Gothic architecture and cobbled backstreets created the breath-taking backdrop for this year’s European Academy of Allergy and Clinical Immunology (EAACI)…

EMJ Allergy & Immunology 4.1 2019

EMJ Allergy Immunology 4.1 brings you a review of this fantastic congress…

Expanding Options in House Dust Mite Allergy Immunotherapy: Optimising Individual Patient Outcomes

Prof Calderón emphasised that the aim of the symposium was to improve outcomes for patients with HDM allergy, noting that…